City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
  PROFILE 
The following is a list of available studies directed by  Joanne Mortimer, MD  
Search results:  3  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-3 Trials Jump to page:

COH Protocol Number: 16451 ClinicalTrials.gov Number: NCT02954874

Principal Investigator: Joanne Mortimer, MD
Sponsor: Cooperative Group

Title:  SWOG S1418/BR006: A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with >= 1 cm Residual Invasive Cancer or Positive Lymph Nodes (ypN+) After Neoadjuvant Chemotherapy

COH Protocol Number: 07100

Principal Investigator: Joanne Mortimer, MD
Sponsor: Institutional

Title:  Long Term Follow-Up After Breast Cancer

COH Protocol Number: 97105

Principal Investigator: Joanne Mortimer, MD
Sponsor: Institutional

Title:  Evaluation of Breast Cancer Patterns and Outcomes of Care

 
Results per page: 25 50 100 All 1-3 Trials Jump to page:

 
 
  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.